Sentences with phrase «share prices for those stocks»

Also rising should be the share prices for those stocks.

«Apple is growing faster than Spotify and has a different business model whereby music does not have to be profitable on a standalone basis,» Tinker wrote and predicted $ 130 per share price for the stock this year.

Not exact matches

The startup's stock price was languishing around $ 36 on April 10 when AT&T swooped in with an offer to buy the company for $ 95.63 per share.

Confused investors sold off enough stock for the share price to plummet 21 % in two days.

Activist investors, who now manage some $ 174 billion in assets, have exploded onto the scene, shaking up boards and pushing for share repurchases, company breakups, or outright sales in order to get stock prices higher.

To be sure, underpriced stocks are often cheap for a reason, because something has gone wrong, either internally or at the sector level, to deflate the share price.

But the almost 4 % jump in Apple's stock price in after - hours trading only got the shares back to around $ 175, the same level where they were back in November and have bounced around for the intervening months.

Apple's stock dipped at the start of 2016 due to concerns over a slowdown in iPhone sales, though share prices have since rebounded into positive territory for the year amid investor optimism for the company's new line of products.

HOUSTON, April 20, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the closing of its previously announced underwritten public offering of 9,200,000 shares of its common stock, including 1,200,000 shares sold pursuant to the underwriters» full exercise of their option to purchase additional shares, at a public offering price of $ 7.50 per share.

Investors had a strong appetite for the company's stock, chomping up shares priced at $ 26 for the debut, and pushing the stock price up more than 50 percent soon after the opening bell at the New York Stock Exchstock, chomping up shares priced at $ 26 for the debut, and pushing the stock price up more than 50 percent soon after the opening bell at the New York Stock Exchstock price up more than 50 percent soon after the opening bell at the New York Stock ExchStock Exchange.

Dramatically swinging stock prices, such as those at the beginning of January, make it very hard to determine the right price for soon - to - be-issued shares.

Despite Icahn's verbal pummelling, most analysts have a Buy rating on the stock and target prices much higher than Icahn's offer to purchase the company for US$ 7 a share.

Moreover, Boeing has been buying back swaths of its own shares — a boon for both its shareholders and its stock price.

The only Wall Street analyst covering the stock, D.A. Davidson's Tom Forte, had subsequently raised his price target on the stock to $ 85 a share, with the retail business accounting for $ 58 a share.

Instead of having banks determine the price of shares before the company officially opens up for trading to the public, Spotify stock price would be determined solely by supply and demand on the market.

Shareholders approved the sale, which paid them $ 13.65 in cash for each share of common stock, a 37 % premium over the recent average closing price.

In late May, when Edward Yruma of Keybanc Capital Markets downgraded the stock, his reservations had more to do with its shares already being priced for perfection at a time when its strategy seemed to be shifting toward testing new products and markets more than driving sales in its yogawear stronghold.

Collect a Check When stock price growth is sluggish, dividends account for a much bigger share of investors» gains.

Those presumptions include the idea that corporate earnings and share prices will rise steadily, well into the future, and thus it will be an appreciating stock market — not cash from company coffers — that will compensate workers who have taken options and their attendant risks as a substitute for salary.

There is no real insurance when it comes to stocks, except for complicated and expensive put options, which give owners the right to sell their shares of a given stock when it hits a particular price, Cramer explained.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

Yield hunters are ignoring warning signs from the «real» economy, pushing share prices for some major stocks higher.

The all - stock transaction values Sprint at 0.10256 per T - Mobile share, or $ 6.62 a share, based on T - Mobile's latest closing price, for a total of about $ 26 billion.

The firm's investigation seeks to determine, among other things, whether the Company's Board of Directors failed to satisfy their duties to shareholders, including whether the Board adequately pursued alternatives to the acquisition and whether the Board obtained the best price possible for the Company's shares of common stock.

He referred to the trend of companies buying back their shares to drive up their stock price, instead of making investments that will benefit the companies for years to come, as simply being unsustainable and dangerous.

Though the IPO only gave Rovio half the market value the company had hoped for ($ 900 million ($ 1.1 billion) instead of its anticipated $ 2 billion), stock bounced back when a bank backing the IPO started purchasing shares to «stabilize» the price, according to Bloomberg.

HOUSTON, April 17, 2018 (GLOBE NEWSWIRE)-- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders, today announced the pricing of an underwritten public offering of 8,000,000 shares of its common stock at a price to the public of $ 7.50 per share.

The gaming giant also announced that during the holiday period, it repurchased 800,500 shares of stock at an average price of $ 49.39 for a total of $ 39.5 million.

Mylan (MYL) will pay $ 205 per share in cash and stock for the Ireland - based drugmaker, representing a 24.2 % premium over its closing price Tuesday.

Goldman Sachs, for one, raised its price target by a full $ 8 to $ 26 a share; by Friday afternoon, Yelp stock had already busted through that goal.

Cowen lowered its rating for the photo messenger's shares to underperform from market perform, predicting a 30 percent decline in stock price over the next year.

Stock options allow employees to purchase shares in their company at a price fixed when the optionis granted (the grant price) for a defined number of years into the future.

And in 2007, with crude prices on the rise, voracious demand for new shares of PetroChina on the Shanghai Stock Exchange caused the Chinese oil and gas company's market value to briefly top $ 1 trillion.

Microsoft Corp., which is in Redmond, Washington, is paying $ 196 for each share of LinkedIn Corp., a 50 per cent premium over the stock's closing price of $ 131.08 on Friday.

It was a little over a year ago that AMD's long - depressed stock price rose above $ 12 a share for the first time since 2007.

The warrants allow Teachers to buy HBC shares at C$ 17 each, which is above Friday's closing price for the stock on the Toronto Stock Exchstock on the Toronto Stock ExchStock Exchange.

After an ugly six weeks in January and February when stocks and oil prices tumbled in tandem, shares in the U.S. and much of the rest of the world have recovered nicely, with the S&P 500 on track to rise by just under 10 % for the year.

In what might represent the concerns over Proton, Citi, for one, noted that the deal would improve the valuation of the seller, raising its target price for DRB - Hicom's shares to 2.30 ringgit from 1.86 ringgit, keeping a Buy / High Risk call on the stock.

Paying CEOs in stock and options sounds innocent enough, but the temptation for them to boost share prices is too tempting to pass up.

Later that afternoon, Reuters reported that Samsung had offered to buy BlackBerry for as much as $ 7.5 billion, valuing its stock at between $ 13.35 to $ 15.49 per share, a 38 percent to 60 percent premium over BlackBerry's trading price at the time.

It plans a special shareholder meeting to get approval for a reverse stock split that would aim to exchange outstanding shares for a smaller number of consolidated shares, with a price in the range of C$ 10 to $ 20 each.

The private - equity firm will pay $ 157 a share in cash for Buffalo Wild Wings, which is 34 % above the company's closing stock price on November 13, the day before Roark's initial bid of $ 150 a share.

By adding one preferred share for each common share could boost Apple's stock price by $ 150, he said.

That may explain why Japan's Suntory jumped ahead of a number of European suitors, including France's Pernod Ricard, to bid for Beam last month — offering to pay Beam stockholders $ 83.50 per share, a 25 % premium over the stock's then - market price of around $ 67, in addition to assuming some $ 2.4 billion in company debt.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Another issue is that the bank usually advises that the company split its stock as many times as it needs to to get the price per share down to around $ 10 before it goes public, logic being that people like to buy in round lots (100 share purchases) and $ 1000 is a workable number for most people.

Camber Capital Management, a hedge fund with an activist history, has purchased 5.7 million shares of Tenet Healthcare Corp., or a 5.7 % stake in the money - losing hospital chain.The emergence of Camber was disclosed Monday, just three days after Tenet's largest shareholder, Glenview Capital Management, resigned two Tenet board seats, citing irreconcilable differences with management and the board.Glenview Capital, which owns an 18 % stake in Tenet, gave notice Friday that it would no longer participate in a stand - still agreement that had prevented it from launching a proxy fight for control of the company.Tenet investors welcomed the Camber disclosure Monday, driving up Tenet's stock price to $ 2.18, or 15 %, to $ 16.63 as of 12:30 p.m. ET.Tenet is the nation's third - largest investor - owned

Accordingly, if an active trading market for our common stock does not develop or is not sustained, the liquidity of our common stock, your ability to sell your shares of common stock when desired and the prices that you may obtain for your shares of common stock will be adversely affected.

Franken also took on Representative Tom Price, Trump's nominee for the Department of Health and Human Services, for owning shares in tobacco companies while voting to do their bidding in Congress and for getting a «sweetheart deal» on biotech stock.

Shares that are exchanged by a participant or withheld by Apple to pay the exercise price of an option or stock appreciation right granted under the 2014 Plan, as well as any shares exchanged or withheld to satisfy the tax withholding obligations related to any option or stock appreciation right, will not be available for subsequent awards under the 2014Shares that are exchanged by a participant or withheld by Apple to pay the exercise price of an option or stock appreciation right granted under the 2014 Plan, as well as any shares exchanged or withheld to satisfy the tax withholding obligations related to any option or stock appreciation right, will not be available for subsequent awards under the 2014shares exchanged or withheld to satisfy the tax withholding obligations related to any option or stock appreciation right, will not be available for subsequent awards under the 2014 Plan.